Compare 16 telehealth providers offering semaglutide and tirzepatide in Chicago. Independent pricing, verified reviews, no sponsored rankings.
Ranked by our editorial score — price, transparency, clinical rigor, and patient satisfaction.
Telehealth platform specializing in affordable compounded GLP-1 medications for weight loss. Known for aggressive pricing on compounded semaglutide and tirzepatide with fast onboarding.
Major telehealth platform offering GLP-1 weight loss programs with compounded and brand-name semaglutide and tirzepatide. Known for accessible pricing and a streamlined digital experience.
Weight-care platform combining GLP-1 medications with behavior change coaching, nutrition guidance, and community support. Takes a holistic approach beyond medication alone.
Publicly traded (NYSE: HIMS) telehealth company offering GLP-1 weight loss treatments alongside men's and women's health services. Offers both compounded and brand-name GLP-1 options.
Telehealth marketplace connecting patients with licensed doctors for peptide therapy, hormone optimization, and wellness prescriptions. Competitive pricing through network model.
Established telemedicine clinic focused on hormone optimization, peptide therapy, and anti-aging medicine. Known for deep clinical expertise and broad peptide catalog.
Telehealth platform specializing in weight loss peptides and hormone therapy, known for competitive pricing on GLP-1 medications.
Metabolic health company offering a comprehensive one-year GLP-1 weight loss program that combines medication with metabolic reset through food, sleep, exercise, and emotional health coaching.
Men's health telehealth platform offering hormone optimization and peptide therapy with at-home lab testing and physician-guided treatment plans.
Large-scale telehealth platform (publicly traded) offering weight management via GLP-1 medications alongside dermatology, hair loss, and primary care services.
Integrated telehealth platform with primary care and specialized peptide/weight-loss programs. Appeals to users wanting peptide therapy within a broader healthcare relationship.
FORM Health is a physician-led obesity medicine practice delivered entirely via telehealth. Unlike platforms that added GLP-1 prescribing to an existing product (Noom, Hims, Ro), FORM was built from the ground up as an obesity medicine specialty practice. Every FORM clinician is a board-certified physician specializing in obesity medicine — not general practitioners doing questionnaire reviews. This clinical depth comes at a premium price point, but delivers a level of medical sophistication tha
Noom started as a behavior-change app focused on psychology-driven weight loss coaching, built around cognitive behavioral therapy (CBT) principles. In 2023, they launched Noom Med, adding GLP-1 prescriptions to their platform. This makes Noom one of the few providers that combines medication with a structured behavioral curriculum — an approach that could help address the weight regain problem associated with GLP-1 discontinuation. The coaching program predates the medication offering by over a
PlushCare is a broad-spectrum telehealth platform offering primary care, mental health, dermatology, and weight management — not a weight-loss-specific company. Acquired by Accolade (publicly traded health services company) in 2021, PlushCare brings the backing of an established healthcare organization. Their generalist model means GLP-1 prescriptions happen within a broader healthcare relationship, and they work extensively with insurance rather than pushing cash-pay compounded medications.
Sequence positions itself as the "clinical-first" GLP-1 telehealth provider. Founded by obesity medicine specialists, the platform emphasizes board-certified clinicians, insurance-first prescribing, and a medically rigorous approach compared to most direct-to-consumer competitors. Their model prioritizes getting patients onto brand-name FDA-approved medications through insurance rather than defaulting to compounded alternatives.
Sesame takes a radically different approach to telehealth GLP-1 access: no subscriptions, no memberships, no monthly fees. You pay per visit, get a prescription if appropriate, and fill it wherever you want. Think of Sesame as the à la carte option — stripped-down, transparent pricing with no ongoing commitments. This model gives patients maximum flexibility but shifts the work of finding affordable medication to the patient.
Monthly semaglutide and tirzepatide pricing across providers serving the Chicago-Naperville-Elgin area.
| Provider | Price | Type | Notes |
|---|---|---|---|
Henry MedsBest price | $149/monthly | Subscription | Compounded semaglutide |
| $149/monthly | Subscription | Compounded semaglutide; brand Wegovy also available | |
| $159/monthly | Subscription | Compounded semaglutide; brand options available at higher cost | |
| $199/monthly | Subscription | Compounded semaglutide | |
| $275/monthly | One-time | Consultation fee separate | |
| $280/monthly | One-time | — | |
| $297/monthly | Subscription | — | |
| $299/monthly | Subscription | Includes 1:1 coaching, labs, and video visits; medication cost separate if not covered by insurance | |
| $299/monthly | Subscription | — | |
| $299/monthly | Subscription | — | |
| $350/monthly | Subscription | May be covered by employer health plan |
| Provider | Price | Type | Notes |
|---|---|---|---|
CalibrateBest price | $299/monthly | Subscription | Same program fee; medication cost varies by insurance |
| $349/monthly | Subscription | Compounded tirzepatide | |
| $375/monthly | One-time | Consultation fee separate | |
| $399/monthly | Subscription | Brand Zepbound | |
| $399/monthly | Subscription | Brand tirzepatide | |
| $399/monthly | Subscription | Brand Zepbound available | |
| $399/monthly | Subscription | — | |
| $399/monthly | Subscription | — | |
| $425/monthly | Subscription | — | |
| $450/monthly | Subscription | May be covered by employer health plan |
Prices reflect telehealth platform costs as of March 2026.See our methodology.
Chicago's large and competitive healthcare market means telehealth GLP-1 providers often offer pricing in line with or slightly below national averages. The city's strong employer-sponsored insurance market can also improve coverage options.
Illinois has comprehensive telehealth legislation permitting prescribing via telehealth. The state requires telehealth parity for insurance coverage and allows a wide range of telehealth services.
Chicago follows Illinois state telehealth regulations, which allow full prescribing authority via telehealth. The city's robust healthcare infrastructure supports both telehealth and hybrid care models.
In-Person Visit Required?
No
Compounding Restrictions?
Yes
Async Telehealth Allowed?
Yes
Telehealth Parity Law?
Yes
Regulations as of 2026. Telehealth laws change frequently. Always verify current requirements with your provider.
Answer 5 quick questions and we'll match you with the best GLP-1 provider available in Chicago, IL.
Take the 2-Minute QuizYes. Chicago residents have access to nearly all major telehealth GLP-1 providers. Illinois regulations support telehealth prescribing without requiring an initial in-person visit.
Yes. Most telehealth platforms serving Chicago offer both brand-name medications like Ozempic and Wegovy as well as compounded semaglutide and tirzepatide at lower price points.
The best provider depends on your needs and budget. Chicago residents can compare platforms like Ro, Hims, Found, and others. Consider factors like medication type, pricing, insurance acceptance, and clinical support.
Telehealth Ally is an independent comparison platform. Our rankings are never influenced by compensation. Provider availability, pricing, and regulations are researched and verified by our editorial team. State telehealth regulations change frequently — always confirm current requirements with your chosen provider. This page is not medical advice.
We track prices so you don't have to.
No spam. Unsubscribe anytime.